Kornitzer Capital Management Inc Ligand Pharmaceuticals Inc Transaction History

Kornitzer Capital Management Inc

$4.73 Billion
Q2 2025

A detailed history of Kornitzer Capital Management Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 91,167 shares of LGND stock, worth $13.9 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

91,167

Previous 135,482 32.71%

Holding current value

$13.9 Million

Previous $14.2 Million 27.25%

% of portfolio

0.22%

Previous 0.31%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	SELL	$96.67 - $118.22 $4.28 Million - $5.24 Million	-44,315 Reduced 32.71%	91,167 $10.4 Million
Q1 2023 May 09, 2023	BUY	$65.67 - $77.08 $1.89 Million - $2.21 Million	28,730 Added 26.91%	135,482 $9.97 Million
Q4 2022 Feb 02, 2023	SELL	$61.72 - $96.74 $1.17 Million - $1.83 Million	-18,940 Reduced 15.07%	106,752 $7.13 Million
Q3 2022 Nov 03, 2022	SELL	$0.01 - $107.56 $947 - $10.2 Million	-94,730 Reduced 42.98%	125,692 $10.8 Million
Q2 2022 Aug 03, 2022	SELL	$74.52 - $117.06 $6.19 Million - $9.72 Million	-83,000 Reduced 27.35%	220,422 $19.7 Million
Q3 2021 Nov 03, 2021	SELL	$102.33 - $144.73 $3.35 Million - $4.74 Million	-32,775 Reduced 9.75%	303,422 $42.3 Million
Q2 2021 Jul 30, 2021	SELL	$113.03 - $155.64 $7.75 Million - $10.7 Million	-68,578 Reduced 16.94%	336,197 $44.1 Million
Q1 2021 Apr 30, 2021	SELL	$99.52 - $215.83 $3.62 Million - $7.86 Million	-36,415 Reduced 8.25%	404,775 $61.7 Million
Q4 2020 Jan 29, 2021	BUY	$80.55 - $106.05 $3.06 Million - $4.03 Million	38,040 Added 9.44%	441,190 $43.9 Million
Q3 2020 Oct 30, 2020	BUY	$89.56 - $126.72 $4.08 Million - $5.77 Million	45,570 Added 12.74%	403,150 $38.4 Million
Q2 2020 Aug 03, 2020	BUY	$68.28 - $123.65 $14.8 Million - $26.9 Million	217,405 Added 155.1%	357,580 $40 Million
Q1 2020 Apr 30, 2020	BUY	$63.37 - $107.88 $2.15 Million - $3.65 Million	33,880 Added 31.87%	140,175 $10.2 Million
Q4 2019 Jan 31, 2020	SELL	$96.94 - $113.59 $1.11 Million - $1.3 Million	-11,468 Reduced 9.74%	106,295 $11.1 Million
Q3 2019 Nov 04, 2019	BUY	$86.25 - $120.16 $603,750 - $841,120	7,000 Added 6.32%	117,763 $11.7 Million
Q2 2019 Jul 31, 2019	SELL	$107.38 - $129.34 $503,612 - $606,604	-4,690 Reduced 4.06%	110,763 $12.6 Million
Q1 2019 May 01, 2019	BUY	$105.93 - $142.47 $2.4 Million - $3.23 Million	22,684 Added 24.45%	115,453 $14.5 Million
Q4 2018 Jan 31, 2019	BUY	$128.36 - $272.13 $3.59 Million - $7.6 Million	27,937 Added 43.09%	92,769 $12.6 Million
Q3 2018 Nov 13, 2018	SELL	$211.18 - $274.49 $1.99 Million - $2.58 Million	-9,400 Reduced 12.66%	64,832 $17.8 Million
Q2 2018 Aug 02, 2018	SELL	$150.77 - $207.98 $149,714 - $206,524	-993 Reduced 1.32%	74,232 $15.4 Million
Q1 2018 Apr 30, 2018	SELL	$138.63 - $182.62 $2.66 Million - $3.5 Million	-19,160 Reduced 20.3%	75,225 $12.4 Million
Q4 2017 Jan 31, 2018	SELL	$128.36 - $147.04 $550,664 - $630,801	-4,290 Reduced 4.35%	94,385 $12.9 Million
Q3 2017 Oct 31, 2017	BUY	$120.91 - $137.94 $11.9 Million - $13.6 Million	98,675	98,675 $13.4 Million

Others Institutions Holding LGND

# of Institutions

293

Shares Held

19.4M

Call Options Held

Put Options Held

3.5K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.58B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.

Account

Kornitzer Capital Management Inc Ligand Pharmaceuticals Inc Transaction History